CA1068608A - Produit pharmaceutique contenant du 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane - Google Patents

Produit pharmaceutique contenant du 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane

Info

Publication number: CA1068608A
Authority: CA; Canada
Prior art keywords: composition according; bis; yloxy; hydroxypropane; pharmaceutically acceptable
Prior art date: 1974-11-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA239,502A

Other languages

English (en)

Other versions

CA239502S (en

Inventor

David J. Robinson

Kenneth Brown

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Fisons Ltd

Original Assignee

Fisons Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1974-11-09

Filing date

1975-11-10

Publication date

1979-12-25

1975-11-10 Application filed by Fisons Ltd filed Critical Fisons Ltd

1979-12-25 Application granted granted Critical

1979-12-25 Publication of CA1068608A publication Critical patent/CA1068608A/fr

Status Expired legal-status Critical Current

Links

IMZMKUWMOSJXDT-UHFFFAOYSA-N cromoglycic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C(O)=O)O2 IMZMKUWMOSJXDT-UHFFFAOYSA-N 0.000 title claims abstract description 8
239000008194 pharmaceutical composition Substances 0.000 title claims abstract 3
239000000203 mixture Substances 0.000 claims abstract description 28
239000007937 lozenge Substances 0.000 claims abstract description 20
239000007910 chewable tablet Substances 0.000 claims abstract description 16
235000010603 pastilles Nutrition 0.000 claims abstract description 13
229940068682 chewable tablet Drugs 0.000 claims abstract description 11
235000015218 chewing gum Nutrition 0.000 claims abstract description 9
150000003839 salts Chemical class 0.000 claims abstract description 9
229940112822 chewing gum Drugs 0.000 claims abstract description 8
239000003085 diluting agent Substances 0.000 claims abstract description 5
239000002671 adjuvant Substances 0.000 claims abstract description 3
QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims description 10
239000004480 active ingredient Substances 0.000 claims description 6
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
239000004816 latex Substances 0.000 claims description 5
229920000126 latex Polymers 0.000 claims description 5
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 4
229930195725 Mannitol Natural products 0.000 claims description 4
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
229930006000 Sucrose Natural products 0.000 claims description 4
239000001913 cellulose Substances 0.000 claims description 4
229920002678 cellulose Polymers 0.000 claims description 4
239000000594 mannitol Substances 0.000 claims description 4
235000010355 mannitol Nutrition 0.000 claims description 4
239000005720 sucrose Substances 0.000 claims description 4
229920001412 Chicle Polymers 0.000 claims description 3
240000001794 Manilkara zapota Species 0.000 claims description 3
235000011339 Manilkara zapota Nutrition 0.000 claims description 3
239000002202 Polyethylene glycol Substances 0.000 claims description 3
229910052783 alkali metal Inorganic materials 0.000 claims description 3
239000003349 gelling agent Substances 0.000 claims description 3
229920001223 polyethylene glycol Polymers 0.000 claims description 3
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
240000000896 Dyera costulata Species 0.000 claims description 2
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
150000001340 alkali metals Chemical class 0.000 claims description 2
239000008103 glucose Substances 0.000 claims description 2
239000008101 lactose Substances 0.000 claims description 2
HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
239000000811 xylitol Substances 0.000 claims description 2
235000010447 xylitol Nutrition 0.000 claims description 2
HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
229960002675 xylitol Drugs 0.000 claims description 2
-1 alkaline earth metal salt Chemical class 0.000 claims 2
229910052784 alkaline earth metal Inorganic materials 0.000 claims 1
125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims 1
208000007117 Oral Ulcer Diseases 0.000 abstract description 2
239000004615 ingredient Substances 0.000 description 8
108010010803 Gelatin Proteins 0.000 description 7
239000008273 gelatin Substances 0.000 description 7
229920000159 gelatin Polymers 0.000 description 7
235000019322 gelatine Nutrition 0.000 description 7
235000011852 gelatine desserts Nutrition 0.000 description 7
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
238000000034 method Methods 0.000 description 5
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
235000021355 Stearic acid Nutrition 0.000 description 3
238000009472 formulation Methods 0.000 description 3
239000000314 lubricant Substances 0.000 description 3
229920000609 methyl cellulose Polymers 0.000 description 3
239000001923 methylcellulose Substances 0.000 description 3
235000010981 methylcellulose Nutrition 0.000 description 3
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
239000008117 stearic acid Substances 0.000 description 3
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
239000011230 binding agent Substances 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
238000001816 cooling Methods 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
239000001525 mentha piperita l. herb oil Substances 0.000 description 2
238000002156 mixing Methods 0.000 description 2
235000019477 peppermint oil Nutrition 0.000 description 2
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
239000001856 Ethyl cellulose Substances 0.000 description 1
ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
239000004902 Softening Agent Substances 0.000 description 1
239000000427 antigen Substances 0.000 description 1
102000036639 antigens Human genes 0.000 description 1
108091007433 antigens Proteins 0.000 description 1
208000002399 aphthous stomatitis Diseases 0.000 description 1
208000006673 asthma Diseases 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
239000006227 byproduct Substances 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
230000001013 cariogenic effect Effects 0.000 description 1
230000001055 chewing effect Effects 0.000 description 1
239000011362 coarse particle Substances 0.000 description 1
238000007906 compression Methods 0.000 description 1
230000006835 compression Effects 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
239000003814 drug Substances 0.000 description 1
229920001249 ethyl cellulose Polymers 0.000 description 1
235000019325 ethyl cellulose Nutrition 0.000 description 1
238000005469 granulation Methods 0.000 description 1
230000003179 granulation Effects 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
239000000463 material Substances 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
239000011591 potassium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011734 sodium Substances 0.000 description 1
239000003826 tablet Substances 0.000 description 1
238000005550 wet granulation Methods 0.000 description 1

Landscapes

Medicinal Preparation (AREA)

CA239,502A 1974-11-09 1975-11-10 Produit pharmaceutique contenant du 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane Expired CA1068608A (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB4849574		1974-11-09

Publications (1)

Publication Number	Publication Date
CA1068608A true CA1068608A (fr)	1979-12-25

Family

ID=10448833

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA239,502A Expired CA1068608A (fr)	1974-11-09	1975-11-10	Produit pharmaceutique contenant du 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane

Country Status (1)

Country	Link
CA (1)	CA1068608A (fr)

1975
- 1975-11-10 CA CA239,502A patent/CA1068608A/fr not_active Expired

Publication	Publication Date	Title
JP2948317B2 (ja)	1999-09-13	噛める薬物投与用組成物
DE3045634C2 (de)	1987-03-19	Pharmazeutisches Präparat mit langsamer Wirkstofffreisetzung und Verfahren zu dessen Herstellung
JP4336021B2 (ja)	2009-09-30	口腔内崩壊型錠剤およびその製造法
AU708197B2 (en)	1999-07-29	Improved rapidly disintegratable multiparticulate tablet
IE64838B1 (en)	1995-09-06	Chewing gum composition with accelerated controlled release of active agents
JP2010006845A (ja)	2010-01-14	新規の配合物及びその使用
US5958445A (en)	1999-09-28	Oral Formulations of S(+)-etodolac
DE69815856T2 (de)	2004-05-06	Cefadroxilmonohydrat tablettenformulierung
JP2000212094A (ja)	2000-08-02	口腔用製剤
AU756805B2 (en)	2003-01-23	Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis
US3341414A (en)	1967-09-12	N-cyclohexylsulfamate solubilized medication
US4146634A (en)	1979-03-27	Composition
IL106743A (en)	1999-11-30	Tablets with improved bioavailability of the active material clodronic acid
US6413541B1 (en)	2002-07-02	Disintegrating tablet in oral cavity and production thereof
EP0205865B1 (fr)	1989-06-21	Préparations pharmaceutiques à effet antihypertenseur et cardioprotecteur
CA1068608A (fr)	1979-12-25	Produit pharmaceutique contenant du 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane
EP1429770B1 (fr)	2009-05-13	Nouvelles formulations et leur utilisation
EP0599767B1 (fr)	2000-10-25	Procédé pour préparer des comprimés hydro-dispersibles contenant du diclofenac
US4416898A (en)	1983-11-22	Therapeutic uses of methionine
EA006582B1 (ru)	2006-02-24	Фармацевтический дезинфицирующий препарат на основе уснината натрия и лекарственных растений, (его варианты) и способы их изготовления
JPH10203963A (ja)	1998-08-04	殺菌性物質と粘膜付着性物質を含む口内投与用医薬品組成物
US3336199A (en)	1967-08-15	Tablet composition
JPS6138170B2 (fr)	1986-08-28
UA79567C2 (en)	2007-06-25	Orodispersible pharmaceutical composition of antithrombolic compound
JPS59101420A (ja)	1984-06-12	インドメタシンを含有する直腸用調製物